← Home / CORMEDIX INC. (CRMD)
Stock Analysis
CORMEDIX INC. (CRMD)
CRMD
CRMD · Market data
7.53 +0.53%
Track CRMD in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when CRMD price is:
52W Range Position
15%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-02 14:46 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Strong / Strong
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
8.06
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
2
●
Management / Board
MEDIUM
CRMD board and management update
(the “Company”) effected a change in its executive leadership structure, whereby the Company’s Board of Directors has appointed Elizabeth Hurlburt, currently the Chief Operating Officer, to the newly created role of Chief Operating and Commercial Officer where she will have functional oversight of all commercial fun...
8-K Filing • SEC EDGAR
JUL
1
●
Auditor Change
MEDIUM
CRMD auditor change
Changes in Registrant’s Certifying Accountant.
8-K Filing • SEC EDGAR
MAY
14
●
Financial Results
HIGH
CORMEDIX THERAPEUTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
CorMedix Therapeutics (Nasdaq: CRMD) today announced financial results for the first quarter ended March 31, 2026 and provided an update on its business.
8-K Filing • SEC EDGAR
What's Driving CRMD?
📈 Technical recovery is improving
Momentum is Neutral. Watch 8.06 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
—
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Triangle Compression / SYM / DOWN
State
Forming
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
8.45
Compression
26%
RSI(14)
41.1
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 6.13 and resistance around 8.06. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.
Price Chart
CRMD — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Fair
Fair valuation
Strong quality metrics make the valuation look balanced rather than simply cheap.
Market Cap
$590.3M
Company size
EV
$413.4M
Debt-adjusted value
P/E
3.3
Low multiple
P/S
1.9
Low sales multiple
P/B
1.4
Low book multiple
EV/Sales
1.3
Low sales multiple
EV/EBIT
2.1
Low multiple
P/FCF
3.0
Low multiple
FCF Yield
32.98%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Strong financial quality
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
↗
Revenue Growth
Strong
●
Profitability
Strong
≈
Cash Flow
Healthy
⚖
Balance Sheet
Strong
💵 Revenue
104.28M
↗ Strong
📈 Net Income
38.60M
↗ Strong
🧮 EPS (Basic)
0.48
↗ Strong
CORMEDIX INC.
Related Opportunities